Epoxomicin also inhibited IFN-γ release by ppCT9–17-, ppCT50–59- and ppCT91–100-specific T cell cloids stimulated with IGR-Heu-TAP tumour cells, while it had only a marginal effect on IFN-γ release by ppCT16–25-specific T cell clones stimulated with IGR-Heu (Fig. 3b). Here, IFNG is linked to neoplasm.